STOCK TITAN

MACOM to Enter into Agreements to Further Strengthen Supply Chain

(Neutral)
Tags

MACOM (NASDAQ:MTSI) will enter Long-Term Supply Agreements (LTSAs) with IQE plc for epitaxial services across multiple technologies and will participate in a financing transaction with IQE. MACOM proposes a £45 million investment via equity and a convertible loan note and will receive a board seat. The transactions are subject to customary closing conditions, including certain regulatory clearances. MACOM says the agreements aim to strengthen supply-chain resilience and support its growth strategy.

Loading...
Loading translation...

Positive

  • LTSAs to secure multi-technology epitaxial supply
  • Proposed £45 million investment in IQE (equity + convertible loan)
  • Board representation at IQE to influence supplier alignment

Negative

  • Transactions subject to customary closing conditions and regulatory clearances
  • Financing participation introduces investment exposure to IQE

News Market Reaction – MTSI

-2.85%
12 alerts
-2.85% Session close to close
-5.3% Trough in 25 hr 4 min
$20.96B Market Cap
0.2x Rel. Volume

In the Apr 27 session, MTSI declined 2.85%, reflecting a moderate negative market reaction. Argus tracked a trough of -5.3% from its starting point during tracking. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights MACOM’s focus on securing epitaxial supply via long-term agreements and...
Analysis

This announcement highlights MACOM’s focus on securing epitaxial supply via long-term agreements and a £45 million equity and convertible loan note investment in IQE, alongside gaining board representation. In recent months, MACOM has complemented such strategic steps with multiple new product introductions across high-speed connectivity. Investors may monitor how this partnership supports MACOM’s growth strategy, the impact on IQE’s balance sheet, and ongoing Form 144 selling activity when evaluating risk, execution, and capital allocation outcomes over time.

Key Figures

Proposed IQE investment: £45 million
1 metrics
Proposed IQE investment £45 million Equity and convertible loan note financing with IQE plc

Historical Context

5 past events · Latest: Apr 23 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Apr 23 Earnings date notice Neutral +2.7% Announcement of Q2 2026 results date and conference call details.
Mar 18 Conference showcase Positive -1.1% Showcasing RF and optical SATCOM solutions at SATShow Week 2026.
Mar 17 Product launch Positive -1.6% Launch of two 448G per lane PAM4 drivers for high-speed optics.
Mar 16 Product availability Positive +4.5% Availability of MACD-41804 cable driver for high-density copper interconnects.
Mar 12 Technology introduction Positive -3.0% Introduction of PCIe 7.0–optimized linear equalizers supporting 128 GT/s.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Product and technology news often drew mixed reactions, with several positive launches met by short-term share price declines.

Recent Company History

This announcement fits a pattern of MACOM pairing strategic initiatives with active product development. Since Mar 12, 2026, the company has introduced PCIe 7.0 linear equalizers, new copper interconnect drivers, and 448G PAM4 drivers, plus showcased broader solutions at SATShow Week. Reactions have been mixed, with some launches sold off despite positive positioning. The new supply agreements and £45 million IQE investment extend this strategy focus while the company approaches its next earnings release on May 7, 2026.

Key Terms

epitaxial, convertible loan note
2 terms
epitaxial technical
"with IQE plc (“IQE”) for epitaxial services spanning multiple technologies."
Epitaxial describes a precision manufacturing process where a thin, orderly layer of material is grown on top of a base crystal so the atoms line up with the underlying structure, much like laying tiles that precisely match an existing pattern. For investors, epitaxial quality affects product performance, manufacturing yield, cost and scalability—so superior epitaxial processes can mean better margins, fewer defects and stronger competitive advantage in sectors like semiconductors and advanced sensors.
convertible loan note financial
"will total £45 million, in the form of equity and a convertible loan note."
A convertible loan note is a debt agreement where an investor lends money to a company with the option to swap that loan for company shares later, often at a set price or discount. It matters to investors because it provides lenders with downside protection (repayment if conversion doesn’t happen) while offering upside if the company grows, and conversion can dilute existing shareholders and change ownership and value per share—like a loan that can become slices of the company’s pie.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LOWELL, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, today announced that it will enter into Long-Term Supply Agreements (“LTSAs”) with IQE plc (“IQE”) for epitaxial services spanning multiple technologies. The LTSAs are expected to further secure supply in support of MACOM’s growth strategy.

In parallel with the LTSAs, subject to customary closing conditions, including obtaining certain regulatory clearances, MACOM will participate in a financing transaction with IQE. MACOM’s proposed investment in IQE will total £45 million, in the form of equity and a convertible loan note. As part of the investment, MACOM will receive representation on IQE’s board of directors.

“IQE is an important supplier to MACOM. We believe this transaction will strengthen our supply chain resilience, while positioning IQE to improve its balance sheet and financial performance across its business,” said Stephen G. Daly, President and Chief Executive Officer, MACOM.

About MACOM
MACOM designs and manufactures semiconductor products for telecommunications, industrial and defense and data center applications. Headquartered in Lowell, Massachusetts, MACOM has design centers and sales offices throughout North America, Europe and Asia. MACOM is certified to the ISO9001 international quality standard and ISO14001 environmental management standard. To learn more, visit https://www.macom.com/.

Special Note Regarding Forward-Looking Statements
This press release contains forward-looking statements based on MACOM management’s beliefs and assumptions and on information currently available to our management. These forward-looking statements include, among others, statements about MACOM’s supply chain resilience and the expected benefits of the transaction to IQE’s balance sheet and financial performance.

These forward-looking statements reflect MACOM’s current views about future events and are subject to risks, uncertainties, assumptions and changes in circumstances that may cause those events or our actual activities or results to differ materially from those indicated by the forward-looking statements, including, among other things, our ability to develop new products and achieve market acceptance of those products; component shortages or other disruptions in our supply chain, including as a result of geopolitical unrest or otherwise; inflationary pressures; any failure to accurately anticipate demand for our products and effectively manage our inventory; our dependence on a limited number of customers; risks related to any weakening of economic conditions; our ability to compete effectively; and those other factors described in “Risk Factors” in MACOM’s filings with the Securities and Exchange Commission (“SEC”), including its Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q and other filings with the SEC. These forward-looking statements speak only as of the date of this press release, and MACOM undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Company Contact:
MACOM Technology Solutions Inc.
Stephen Ferranti
Senior Vice President, Corporate Development and Investor Relations
P: 978-656-2977
E: stephen.ferranti@macom.com


FAQ

What did MACOM (MTSI) announce about supply agreements with IQE on April 27, 2026?

MACOM announced it will enter Long-Term Supply Agreements (LTSAs) with IQE for epitaxial services. According to the company, the LTSAs cover multiple technologies and aim to further secure supply in support of MACOM's growth strategy.

How much is MACOM investing in IQE and in what form for the April 27, 2026 transaction?

MACOM proposed a total investment of £45 million in IQE via equity and a convertible loan note. According to the company, the financing is part of a parallel transaction alongside the LTSAs and includes a board representation arrangement.

Are the MACOM–IQE agreements final as of April 27, 2026 and what conditions apply?

No, the agreements are not final; they are subject to customary closing conditions. According to the company, obtaining certain regulatory clearances and other closing conditions remain before completion can occur.

What strategic benefit did MACOM cite for the IQE LTSAs and investment (MTSI)?

MACOM said the transactions are intended to strengthen supply-chain resilience and support growth. According to the company, the combination of LTSAs and the investment is meant to secure supply and improve IQE's balance sheet and performance.

Will MACOM have governance influence at IQE after the investment announced April 27, 2026?

Yes, MACOM will receive representation on IQE's board of directors as part of the investment. According to the company, the board seat is included in the proposed investment terms alongside the equity and convertible loan note.